LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $825,656 | +12.5% | 11,452 | +14.8% | 0.01% | 0.0% |
| Q1 2023 | $733,615 | +92.0% | 9,973 | +148.7% | 0.01% | +25.0% |
| Q3 2020 | $382,000 | -13.8% | 4,010 | +1.3% | 0.01% | -20.0% |
| Q2 2020 | $443,000 | -54.6% | 3,958 | -44.9% | 0.01% | -58.3% |
| Q4 2018 | $975,000 | -56.7% | 7,188 | -12.4% | 0.02% | -48.9% |
| Q3 2018 | $2,251,000 | +21.5% | 8,202 | -8.3% | 0.05% | +17.5% |
| Q2 2018 | $1,852,000 | +63.3% | 8,941 | +8.0% | 0.04% | +60.0% |
| Q4 2017 | $1,134,000 | -4.9% | 8,282 | -5.5% | 0.02% | -10.7% |
| Q3 2017 | $1,193,000 | +353.6% | 8,760 | +256.1% | 0.03% | +250.0% |
| Q1 2016 | $263,000 | -11.1% | 2,460 | -28.8% | 0.01% | -20.0% |
| Q3 2015 | $296,000 | – | 3,453 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |